1,303
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Low-dose cyclooxygenase-2 (COX-2) inhibitor celecoxib plays a protective role in the rat model of neonatal necrotizing enterocolitis

Pages 7223-7234 | Received 16 Aug 2021, Accepted 09 Sep 2021, Published online: 21 Sep 2021

References

  • Cigsar EB, Karadag CA, Tanik C, et al. The protective effects of sesamol in a neonatal rat model of necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2020;33(6):889–894.
  • Alganabi M, Zhu H, O’Connell JS, et al. Calcium/calmodulin-dependent protein kinase IV signaling pathway is upregulated in experimental necrotizing enterocolitis. Pediatr Surg Int. 2020;36(3):271–277.
  • Rentea RM, Rentea MJ, Biesterveld B, et al. Factors known to influence the development of necrotizing enterocolitis to modify expression and activity of intestinal alkaline phosphatase in a newborn neonatal rat model. Eur J Pediatr Surg. 2019;29(3):290–297.
  • Mokshagundam S, Ding T, Rumph JT, et al. Developmental 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure of either parent enhances the risk of necrotizing enterocolitis in neonatal mice. Birth Defects Res. 2020;112(16):1209–1223.
  • Shi Y, Liu T, Zhao X, et al. Vitamin D ameliorates neonatal necrotizing enterocolitis via suppressing TLR4 in a murine model. Pediatr Res. 2018;83(5):1024–1030.
  • Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255–264.
  • Matsunaga A, Kawamoto M, Shiraishi S, et al. Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats. Eur J Pharmacol. 2007;554(1):255–264.
  • Daham K, James A, Balgoma D, et al. Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma. J Allergy Clin Immunol. 2014;134(2):306–313.
  • Curtis E, Fuggle N, Shaw S, et al. Safety of cyclooxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging. 2019;36(S1):25–44.
  • Erkan G, Gonul II, Kandilci U, et al. Assessment of COX-2 expression presence and severity by immunohistochemical method in patients with chronic active gastritis and intestinal metaplasia. Turk J Gastroenterol. 2012;23(5):478–484.
  • Harris RE. Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. Subcell Biochem. 2007;42:93–126.
  • Bergholz R, Zschiegner M, Eschenburg G, et al. Mucosal loss with increased expression of IL-6, IL-8, and COX-2 in a formula-feeding only neonatal rat model of necrotizing enterocolitis. J Pediatr Surg. 2013;48(11):2301–2307.
  • Karadeniz Cerit K, Koyuncuoglu T, Yagmur D, et al. Nesfatin-1 ameliorates oxidative bowel injury in rats with necrotizing enterocolitis: The role of the microbiota composition and claudin-3 expression. J Pediatr Surg. 2020;55(12):2797–2810.
  • Isani M, Illingworth L, Herman E, et al. Soybean-derived recombinant human epidermal growth factor protects against experimental necrotizing enterocolitis. J Pediatr Surg. 2018;53(6):1203–1207.
  • Lu H, Zhu B. Role of cyclooxygenase-2 in intestinal injury in neonatal rats. Biomed Rep. 2014;2(6):875–878.
  • Yellepeddi VK, Radhakrishnan J, Radhakrishnan R. Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue. Prostate. 2018;78(2):80–85.
  • Safaeian L, Hajhashemi V, Ajoodanian M. The effect of celecoxib on blood pressure and plasma oxidant/antioxidant status in co-administration with glucocorticoid in rat. Biomed Pharmacother. 2018;108:1804–1808.
  • Akinbade AO, Ndukwe KC, Owotade FJ. Comparative analgesic efficacy and tolerability of celecoxib and tramadol on postoperative pain after mandibular third molar extraction: a double blind randomized controlled trial. Niger J Clin Pract. 2019;22(6):796–800.
  • Larussa T, Suraci E, Leone I, et al. Short-term therapy with celecoxib and lansoprazole modulates Th1/ Th2 immune response in human gastric mucosa. Helicobacter. 2010;15(5):449–459.
  • Baker J, Cotter JD, Gerrard DF, et al. Effects of indomethacin and celecoxib on renal function in athletes. Med Sci Sports Exerc. 2005;37(5):712–717.
  • Ruzov M, Rimon G, Pikovsky O, et al. Celecoxib interferes to a limited extent with aspirin-mediated inhibition of platelets aggregation. Br J Clin Pharmacol. 2016;81(2):316–326.
  • Golden J, Illingworth L, Kavarian P, et al. ep2 receptor blockade attenuates COX-2 upregulation during intestinal inflammation. Shock. 2019.
  • Council, N.R., 2011. Guide for the Care and Use of Laboratory Animals: Eighth Edition. The National Academies Press, Washington, DC.
  • Yazici S, Ozcan CU, Hismiogullari AA, et al. Protective effects of quercetin on necrotizing enterocolitis in a neonatal rat model. Am J Perinatol. 2018;35(5):434–440.
  • Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497–500.
  • Koyuncu I, Kocyigit A, Gonel A, et al. The protective effect of naringenin-oxime on cisplatin-induced toxicity in rats. Biochem Res Int. 2017;2017:9478958.
  • Asadi N, Kheradmand A, Gholami M, et al. Effect of royal jelly on testicular antioxidant enzymes activity, MDA level and spermatogenesis in rat experimental Varicocele model. Tissue Cell. 2019;57:70–77.
  • Janssen Lok M, Miyake H, Hock A, et al. Value of abdominal ultrasound in management of necrotizing enterocolitis: a systematic review and meta-analysis. Pediatr Surg Int. 2018;34(6):589–612.
  • Alganabi M, Lee C, Bindi E, et al. Recent advances in understanding necrotizing enterocolitis. F1000Res. 2019;8:107.
  • Rees CM. Surgical strategies for necrotising enterocolitis: a survey of practice in the United Kingdom. Arch Dis Child Fetal Neonatal Ed. 2005;90(2):F152–5.
  • Okur H, Kucukaydin M, Kose K, et al. Hypoxia-induced necrotizing enterocolitis in the immature rat: the role of lipid peroxidation and management by vitamin E. J Pediatr Surg. 1995;30(10):1416–1419.
  • Nadler EP, Dickinson E, Knisely A, et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res. 2000;92(1):71–77.
  • Golden JM, Escobar OH, Nguyen MVL, et al. Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms. Am J Physiol Gastrointest Liver Physiol. 2018;315:G259–G71.
  • Liang S, Lai P, Li X, et al. Ulinastatin reduces the severity of intestinal damage in the neonatal rat model of necrotizing enterocolitis. Med Sci Monit. 2019;25:9123–9130.
  • Temp FR, Marafiga JR, Milanesi LH, et al. Cyclooxygenase-2 inhibitors differentially attenuate pentylenetetrazol-induced seizures and increase of pro- and anti-inflammatory cytokine levels in the cerebral cortex and hippocampus of mice. Eur J Pharmacol. 2017;810:15–25.
  • Morales-Sosa M, Orozco-Suarez S, Vega-Garcia A, et al. Immunomodulatory effect of Celecoxib on HMGB1/TLR4 pathway in a recurrent seizures model in immature rats. Pharmacol Biochem Behav. 2018;170:79–86.
  • Liu D, Wang Y, Li L, et al. Celecoxib protects hyperoxia-induced lung injury via NF-kappaB and AQP1. Front Pediatr. 2019;7:228.
  • Yin J, Zhuang J, Lv S, et al. Study on a 65-mer peptide mimetic enzyme with GPx and SOD dual function. J Mol Recognit. 2018;31(8):e2714.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–1111.
  • Tayman C, Aydemir S, Yakut I, et al. TNF-alpha blockade efficiently reduced severe intestinal damage in necrotizing enterocolitis. J Invest Surg. 2016;29(4):209–217.
  • Karadag A, Ozdemir R, Kurt A, et al. Protective effects of dexpanthenol in an experimental model of necrotizing enterocolitis. J Pediatr Surg. 2015;50(7):1119–1124.
  • Quintero-Garcia M, Delgado-Gonzalez E, Sanchez-Tusie A, et al. Iodine prevents the increase of testosterone-induced oxidative stress in a model of rat prostatic hyperplasia. Free Radic Biol Med. 2018;115:298–308.
  • Senbel AM, AbdelMoneim L, Omar AG. Celecoxib modulates nitric oxide and reactive oxygen species in kidney ischemia/reperfusion injury and rat aorta model of hypoxia/reoxygenation. Vascul Pharmacol. 2014;62(1):24–31.
  • Koul A, Arora N. Celecoxib mitigates cigarette smoke induced oxidative stress in mice. Indian J Biochem Biophys. 2010;47:285–291.
  • Valvassori SS, Tonin PT, Dal-Pont GC, et al. Coadministration of lithium and celecoxib reverses manic-like behavior and decreases oxidative stress in a dopaminergic model of mania induced in rats. Transl Psychiatry. 2019;9(1):297.
  • Gomes RO, Artigiani RN, Guimaraes JFN, et al. Neonatal necrotizing enterocolitis rat model attenuated by a remote ischemic preconditioning in the pregnant. Acta Cir Bras. 2017;32(3):236–242.
  • Na HK, Surh YJ. Induction of cyclooxygenase-2 in Ras-transformed human mammary epithelial cells undergoing apoptosis. Ann N Y Acad Sci. 2002;973(1):153–160.
  • Piplani H, Vaish V, Sanyal SN. Dolastatin 15, a mollusk linear peptide, and Celecoxib, a selective cyclooxygenase-2 inhibitor, prevent preneoplastic colonic lesions and induce apoptosis through inhibition of the regulatory transcription factor NF-kappaB and an inflammatory protein, iNOS. Eur J Cancer Prev. 2012;21(6):511–522.
  • Jilling T, Lu J, Jackson M, et al. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res. 2004;55(4):622–629.
  • van Heumen BW, Roelofs HM, te Morsche RH, et al. Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls. Orphanet J Rare Dis. 2013;8(1):181.
  • Choudhary GS, Al-Harbi S, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 2015;1219:1–9.